Now showing items 1-1 of 1

    • Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor 

      Katz, Steven C; Burga, Rachel A; Naheed, Seema; Licata, Lauren A; Thorn, Mitchell; Osgood, Doreen; Nguyen, Cang T; Espat, N Joseph; Fletcher, Jonathan A.; Junghans, Richard P (BioMed Central, 2013)
      Background: Imatinib mesylate is an effective treatment for metastatic gastrointestinal stromal tumor (GIST). However, most patients eventually develop resistance and there are few other treatment options. Immunotherapy ...